IP Library Granted Patent US 10,653,659
Granted Patent B2
US 10,653,659 · App. 15/527,873 · Granted May 19, 2020

Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,659
App. No.
15/527,873
Granted
May 19, 2020
Kind
B2
Abstract

Compositions including a compound of the family of avermectins, preferably ivermectin, and an agonist compound for at least one of the retinoic acid receptors are described. The compositions are in particular used in the treatment of acne.

Claims (9)

1. A topical composition, consisting of:

(a) 0.1% to 2% by weight, relative to the total weight of the composition, of ivermectin;

(b) 0.001% to 1% by weight, relative to the total weight of the composition, of trifarotene; and

(c) one or more pharmaceutically acceptable excipients.

2. The composition according to claim 1 , wherein the ivermectin is present in an amount of 1% by weight, relative to the total weight of the composition, and the trifarotene is present in an amount from 0.005% to 1% by weight, relative to the total weight of the composition.

3. The composition according to claim 1 , wherein the composition is formulated for topical administration.

4. The composition according to claim 1 , wherein the composition is in the form of a gel, a lotion or a cream.

5. The composition according to claim 1 , wherein the ivermectin is present in an amount of 1% by weight, relative to the total weight of the composition.

6. The composition according to claim 1 , wherein the trifarotene is present in an amount of 0.005% by weight, relative to the total weight of the composition.

Assignments (4)
CHANGE OF ADDRESS Recorded Jun 28, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 060541/0374 →
ASSET TRANSFER AGREEMENT Recorded Oct 3, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057698/0295 →
CHANGE OF NAME Recorded Oct 3, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057698/0356 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2020
From: CHAPPUIS, JEAN-PAUL; JACOVELLA, JEAN
To: GALDERMA S.A.
Reel/Frame 052408/0626 →